2022-09-012023-08-312023-08-31false06338124EPI-CURE CONSULTING LIMITED2023-11-20iso4217:GBPxbrli:pure063381242022-09-01063381242023-08-31063381242022-09-012023-08-31063381242021-09-01063381242022-08-31063381242021-09-012022-08-3106338124bus:SmallEntities2022-09-012023-08-3106338124bus:AuditExempt-NoAccountantsReport2022-09-012023-08-3106338124bus:FullAccounts2022-09-012023-08-3106338124bus:PrivateLimitedCompanyLtd2022-09-012023-08-3106338124core:WithinOneYear2023-08-3106338124core:AfterOneYear2023-08-3106338124core:WithinOneYear2022-08-3106338124core:AfterOneYear2022-08-3106338124core:ShareCapital2023-08-3106338124core:SharePremium2023-08-3106338124core:RevaluationReserve2023-08-3106338124core:OtherReservesSubtotal2023-08-3106338124core:RetainedEarningsAccumulatedLosses2023-08-3106338124core:ShareCapital2022-08-3106338124core:SharePremium2022-08-3106338124core:RevaluationReserve2022-08-3106338124core:OtherReservesSubtotal2022-08-3106338124core:RetainedEarningsAccumulatedLosses2022-08-3106338124core:LandBuildings2023-08-3106338124core:PlantMachinery2023-08-3106338124core:Vehicles2023-08-3106338124core:FurnitureFittings2023-08-3106338124core:OfficeEquipment2023-08-3106338124core:NetGoodwill2023-08-3106338124core:IntangibleAssetsOtherThanGoodwill2023-08-3106338124core:ListedExchangeTraded2023-08-3106338124core:UnlistedNon-exchangeTraded2023-08-3106338124core:LandBuildings2022-08-3106338124core:PlantMachinery2022-08-3106338124core:Vehicles2022-08-3106338124core:FurnitureFittings2022-08-3106338124core:OfficeEquipment2022-08-3106338124core:NetGoodwill2022-08-3106338124core:IntangibleAssetsOtherThanGoodwill2022-08-3106338124core:ListedExchangeTraded2022-08-3106338124core:UnlistedNon-exchangeTraded2022-08-3106338124core:LandBuildings2022-09-012023-08-3106338124core:PlantMachinery2022-09-012023-08-3106338124core:Vehicles2022-09-012023-08-3106338124core:FurnitureFittings2022-09-012023-08-3106338124core:OfficeEquipment2022-09-012023-08-3106338124core:NetGoodwill2022-09-012023-08-3106338124core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3106338124core:ListedExchangeTraded2022-09-012023-08-3106338124core:UnlistedNon-exchangeTraded2022-09-012023-08-3106338124core:MoreThanFiveYears2022-09-012023-08-3106338124core:Non-currentFinancialInstruments2023-08-3106338124core:Non-currentFinancialInstruments2022-08-3106338124dpl:CostSales2022-09-012023-08-3106338124dpl:DistributionCosts2022-09-012023-08-3106338124core:LandBuildings2022-09-012023-08-3106338124core:PlantMachinery2022-09-012023-08-3106338124core:Vehicles2022-09-012023-08-3106338124core:FurnitureFittings2022-09-012023-08-3106338124core:OfficeEquipment2022-09-012023-08-3106338124dpl:AdministrativeExpenses2022-09-012023-08-3106338124core:NetGoodwill2022-09-012023-08-3106338124core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3106338124dpl:GroupUndertakings2022-09-012023-08-3106338124dpl:ParticipatingInterests2022-09-012023-08-3106338124dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3106338124core:ListedExchangeTraded2022-09-012023-08-3106338124dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3106338124core:UnlistedNon-exchangeTraded2022-09-012023-08-3106338124dpl:CostSales2021-09-012022-08-3106338124dpl:DistributionCosts2021-09-012022-08-3106338124core:LandBuildings2021-09-012022-08-3106338124core:PlantMachinery2021-09-012022-08-3106338124core:Vehicles2021-09-012022-08-3106338124core:FurnitureFittings2021-09-012022-08-3106338124core:OfficeEquipment2021-09-012022-08-3106338124dpl:AdministrativeExpenses2021-09-012022-08-3106338124core:NetGoodwill2021-09-012022-08-3106338124core:IntangibleAssetsOtherThanGoodwill2021-09-012022-08-3106338124dpl:GroupUndertakings2021-09-012022-08-3106338124dpl:ParticipatingInterests2021-09-012022-08-3106338124dpl:GroupUndertakingscore:ListedExchangeTraded2021-09-012022-08-3106338124core:ListedExchangeTraded2021-09-012022-08-3106338124dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-09-012022-08-3106338124core:UnlistedNon-exchangeTraded2021-09-012022-08-3106338124core:NetGoodwill2023-08-3106338124core:IntangibleAssetsOtherThanGoodwill2023-08-3106338124core:LandBuildings2023-08-3106338124core:PlantMachinery2023-08-3106338124core:Vehicles2023-08-3106338124core:FurnitureFittings2023-08-3106338124core:OfficeEquipment2023-08-3106338124core:AfterOneYear2023-08-3106338124core:WithinOneYear2023-08-3106338124core:ListedExchangeTraded2023-08-3106338124core:UnlistedNon-exchangeTraded2023-08-3106338124core:ShareCapital2023-08-3106338124core:SharePremium2023-08-3106338124core:RevaluationReserve2023-08-3106338124core:OtherReservesSubtotal2023-08-3106338124core:RetainedEarningsAccumulatedLosses2023-08-3106338124core:NetGoodwill2022-08-3106338124core:IntangibleAssetsOtherThanGoodwill2022-08-3106338124core:LandBuildings2022-08-3106338124core:PlantMachinery2022-08-3106338124core:Vehicles2022-08-3106338124core:FurnitureFittings2022-08-3106338124core:OfficeEquipment2022-08-3106338124core:AfterOneYear2022-08-3106338124core:WithinOneYear2022-08-3106338124core:ListedExchangeTraded2022-08-3106338124core:UnlistedNon-exchangeTraded2022-08-3106338124core:ShareCapital2022-08-3106338124core:SharePremium2022-08-3106338124core:RevaluationReserve2022-08-3106338124core:OtherReservesSubtotal2022-08-3106338124core:RetainedEarningsAccumulatedLosses2022-08-3106338124core:NetGoodwill2021-09-0106338124core:IntangibleAssetsOtherThanGoodwill2021-09-0106338124core:LandBuildings2021-09-0106338124core:PlantMachinery2021-09-0106338124core:Vehicles2021-09-0106338124core:FurnitureFittings2021-09-0106338124core:OfficeEquipment2021-09-0106338124core:AfterOneYear2021-09-0106338124core:WithinOneYear2021-09-0106338124core:ListedExchangeTraded2021-09-0106338124core:UnlistedNon-exchangeTraded2021-09-0106338124core:ShareCapital2021-09-0106338124core:SharePremium2021-09-0106338124core:RevaluationReserve2021-09-0106338124core:OtherReservesSubtotal2021-09-0106338124core:RetainedEarningsAccumulatedLosses2021-09-0106338124core:AfterOneYear2022-09-012023-08-3106338124core:WithinOneYear2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:CostValuation2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-09-012023-08-3106338124core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3106338124core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3106338124core:Non-currentFinancialInstrumentscore:CostValuation2022-08-3106338124core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-08-3106338124core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-08-3106338124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-08-3106338124core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-08-3106338124core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-08-3106338124core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-08-3106338124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-08-3106338124core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-08-3106338124bus:Director12022-09-012023-08-3106338124core:FurnitureFittingsToolsEquipment2022-08-3106338124core:FurnitureFittingsToolsEquipment2023-08-31

EPI-CURE CONSULTING LIMITED

Registered Number
06338124
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2023

EPI-CURE CONSULTING LIMITED
Company Information
for the year from 1 September 2022 to 31 August 2023

Director

HOWE, Jeannette Ann

Registered Address

Linen Hall 162-168 Regent Street Room 252-254
London
W1B 5TB

Registered Number

06338124 (England and Wales)
EPI-CURE CONSULTING LIMITED
Balance Sheet as at
31 August 2023

Notes

2023

2022

£

£

£

£

Current assets
Debtors8144144
Cash at bank and on hand41,68743,015
41,83143,159
Creditors amounts falling due within one year10(1,680)(3,413)
Net current assets (liabilities)40,15139,746
Total assets less current liabilities40,15139,746
Net assets40,15139,746
Capital and reserves
Called up share capital11
Profit and loss account40,15039,745
Shareholders' funds40,15139,746
The financial statements were approved and authorised for issue by the Director on 20 November 2023, and are signed on its behalf by:
HOWE, Jeannette Ann
Director
Registered Company No. 06338124
EPI-CURE CONSULTING LIMITED
Notes to the Financial Statements
for the year ended 31 August 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company in the year under review was that of business consultancy.
4.Basis of measurement used in financial statements
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
5.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
6.Employee information

20232022
Average number of employees during the year00
7.Property, plant and equipment

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 September 221,2563,4075,92210,585
At 31 August 231,2563,4075,92210,585
Depreciation and impairment
At 01 September 221,2563,4075,92210,585
At 31 August 231,2563,4075,92210,585
Net book value
At 31 August 23----
At 31 August 22----
8.Debtors

2023

2022

££
Other debtors144144
Total144144
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
9.Debtors within one year

2023

2022

££
Other debtors144144
Total144144
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
10.Creditors within one year

2023

2022

££
Amounts owed to related parties-1,733
Accrued liabilities and deferred income1,6801,680
Total1,6803,413
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.